WC Faquin, MD, PhD
@bfaquin
Surgical pathologist; Cytopathologist; Head & Neck Path; MGH & MEEI; Professor of Path Harvard Medical School; Bonsai enthusiast; Partner: Judson Evans (poet)
ID: 253173545
16-02-2011 18:15:18
2,2K Tweet
5,5K Followers
1,1K Following
February's CytoSource focuses on heightened (but variable) #COVID19 risks for pats w/ cancer. Multiple studies have underscored cancer-associated dangers while reaffirming the protective effects of #vaccination & other prevention strategies. acsjournals.onlinelibrary.wiley.com/doi/full/10.10… Bryn Nelson
Read our March issue! 📘 acsjournals.onlinelibrary.wiley.com/toc/19346638/2… In this issue: 🔹 Mark CC Chen, M.D. FIAC et al on small-volume biopsy of follicular lymphoma 🔹 Andrew A. Renshaw MD and Martha B. Pitman,MD on ROM in renal biopsy 🔹 Chris VandenBussche et al on urine cytology in the detection of RCCs #cytopath
Recruitment and retention woes, a lack of sustained investment, and partisan harassment and attacks are creating a mounting crisis for public health efforts, including cancer prevention. Read the latest CytoSource: acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn… Bryn Nelson @billfaquin
Thyroid nodules with DICER1 mutation or PTEN alteration: A comparative cytologic, clinical, and molecular study of 117 FNA cases - Jitpasutham - Cancer Cytopathology - Wiley Online Library acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn… WC Faquin, MD, PhD Maria Gubbiotti Vania Nosé, MD, PhD Penn Path & Lab Medicine
New! DICER1 and PTEN FNAs reveal many cytologic similarities. DICER1 patients are younger, and PTEN patients had multinodular disease. Awareness of these genetic cohorts can identify patients at risk for thyroid cancer. acsjournals.onlinelibrary.wiley.com/doi/full/10.10… WC Faquin, MD, PhD Zubair Baloch #CytoPath
📣 It's that time again! We're hosting a #CytoChat all about the #BethesdaSystem for Reporting Thyroid Cytopathology, led by our EIC WC Faquin, MD, PhD & Associate Editors Esther Diana Rossi Sinchita Roy MD PhD Michiya Nishino, MD, PhD 🔬 Join us & other leading experts on June 18 at 11am EDT! #CytoPath
Just in time for #FNAFriday! Cytology has a low sensitivity for differentiated high-grade thyroid carcinoma (DHGTC), although a subset of DHGTCs have cytologic features raising the possibility of a high-grade thyroid carcinoma. acsjournals.onlinelibrary.wiley.com/doi/full/10.10… Vanda Torous MD #CytoPath
📣 Join us TODAY at 11am EDT for a #CytoChat on the #BethesdaSystem for Reporting Thyroid Cytopathology, co-hosted by our Editor-in-Chief WC Faquin, MD, PhD & Associate Editors Esther Diana Rossi Sinchita Roy MD PhD Michiya Nishino, MD, PhD! 🔬 #CytoPath
Read our July issue! 📘 acsjournals.onlinelibrary.wiley.com/toc/19346638/2… In this issue: 👉 Marc P. Pusztaszeri MD, PhD (McGill University) on molecular testing of SG FNA specimens 👉 Martha B. Pitman,MD et al on World Health Organization (WHO) system for pancreaticobiliary #CytoPath 👉 Guoping Cai, MD et al on pancreatic serous cystadenoma
Our latest edition of CytoSource covers how Facebook, X, and other social media platforms can aid patient education and recruitment efforts in studying rare cancers. acsjournals.onlinelibrary.wiley.com/doi/full/10.10… Bryn Nelson WC Faquin, MD, PhD OncoAlert
Free access! Claudin18.2 expression and clinicopathological features in #cytology effusion specimens from gastric adenocarcinoma: A comparative study with tissue specimens acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn… #CytoPath CC: Sinchita Roy MD PhD
How do physicians and patients decide on thyroid nodule treatment amidst diagnostic uncertainty? Dr. Pamela Hartzband of BIDMC discusses how risk stratification, molecular testing, and patient values shape treatment decisions. acsjournals.onlinelibrary.wiley.com/doi/epdf/10.10… CC: Michiya Nishino, MD, PhD
Revisit this 2023 review that explores the technology of tumor #organoids and discusses the fundamental application of #cytology as a simple and cost-effective approach toward organoid development. acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn… #CytoPath Rema (Rao) Chaari Chong-xian Pan，MD, PhD, MS
